• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Fecal transplantation: digestive and extradigestive clinical applications.粪便移植:消化及消化外临床应用
Clujul Med. 2018 Jul;91(3):259-265. doi: 10.15386/cjmed-946. Epub 2018 Jul 31.
2
Fecal microbiota transplantation: past, present and future.粪便微生物移植:过去、现在和未来。
Curr Opin Gastroenterol. 2013 Jan;29(1):79-84. doi: 10.1097/MOG.0b013e32835a4b3e.
3
[Efficacy analysis of fecal microbiota transplantation in the treatment of 2010 patients with intestinal disorders].[粪便微生物群移植治疗2010例肠道疾病患者的疗效分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Sep 25;22(9):861-868. doi: 10.3760/cma.j.issn.1671-0274.2019.09.011.
4
Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.炎症性肠病患者艰难梭菌感染的粪便微生物群移植结局
Dig Dis Sci. 2017 Oct;62(10):2870-2875. doi: 10.1007/s10620-017-4580-4. Epub 2017 Apr 27.
5
Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.炎症性肠病影响复发性艰难梭菌感染粪便微生物群移植的结果。
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1433-8. doi: 10.1016/j.cgh.2016.02.018. Epub 2016 Feb 22.
6
[Association between the clinical efficacy of fecal microbiota transplantation in recipients and the choice of donor].[粪便微生物群移植受者的临床疗效与供体选择之间的关联]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Jul 10;23(Z1):69-76. doi: 10.3760/cma.j.cn.441530-20200417-00222.
7
Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.澳大利亚粪便微生物群移植治疗复发性艰难梭菌感染的经济学评估
J Gastroenterol Hepatol. 2016 Dec;31(12):1927-1932. doi: 10.1111/jgh.13402.
8
A systematic review of economic evaluation in fecal microbiota transplantation.粪菌移植的经济学评价系统综述
Infect Control Hosp Epidemiol. 2020 Apr;41(4):458-466. doi: 10.1017/ice.2019.371. Epub 2020 Jan 24.
9
Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review.粪菌移植作为胃肠病学的新型疗法:一项系统综述。
World J Gastroenterol. 2015 May 7;21(17):5359-71. doi: 10.3748/wjg.v21.i17.5359.
10
Current applications of fecal microbiota transplantation in intestinal disorders.粪便微生物群移植在肠道疾病中的应用现状。
Kaohsiung J Med Sci. 2019 Jun;35(6):327-331. doi: 10.1002/kjm2.12069. Epub 2019 Apr 24.

引用本文的文献

1
Unraveling the gut microbiota's role in PCOS: a new frontier in metabolic health.揭示肠道微生物群在多囊卵巢综合征中的作用:代谢健康的新前沿。
Front Endocrinol (Lausanne). 2025 Mar 18;16:1529703. doi: 10.3389/fendo.2025.1529703. eCollection 2025.
2
Fecal microbiota transplantation modulates jejunal host-microbiota interface in weanling piglets.粪便微生物群移植可调节断奶仔猪空肠的宿主-微生物群界面。
Microbiome. 2025 Feb 7;13(1):45. doi: 10.1186/s40168-025-02042-9.
3
Fecal Microbiota Transplantation: Insights into Colon Carcinogenesis and Immune Regulation.粪便微生物群移植:对结肠癌发生和免疫调节的见解。
J Clin Med. 2024 Nov 1;13(21):6578. doi: 10.3390/jcm13216578.
4
Fecal microbiota transplantation and next-generation therapies: A review on targeting dysbiosis in metabolic disorders and beyond.粪便微生物群移植及新一代疗法:关于针对代谢紊乱及其他疾病中微生物失调的综述
SAGE Open Med. 2024 May 31;12:20503121241257486. doi: 10.1177/20503121241257486. eCollection 2024.
5
Probiotic-derived ferrichrome induces DDIT3-mediated antitumor effects in esophageal cancer cells.益生菌衍生的铁载体在食管癌细胞中诱导DDIT3介导的抗肿瘤作用。
Heliyon. 2024 Mar 15;10(6):e28070. doi: 10.1016/j.heliyon.2024.e28070. eCollection 2024 Mar 30.
6
Therapeutic Perspectives for Microbiota Transplantation in Digestive Diseases and Neoplasia-A Literature Review.消化系统疾病和肿瘤中微生物群移植的治疗前景——文献综述
Pathogens. 2023 May 26;12(6):766. doi: 10.3390/pathogens12060766.
7
Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review.结直肠癌的当前及新出现的治疗方法:全面综述
World J Gastrointest Surg. 2023 Apr 27;15(4):495-519. doi: 10.4240/wjgs.v15.i4.495.
8
Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta-analysis of randomized control trials.粪便微生物群移植治疗肠易激综合征的疗效和安全性:基于随机对照试验荟萃分析的最新进展
Health Sci Rep. 2022 Sep 12;5(5):e814. doi: 10.1002/hsr2.814. eCollection 2022 Sep.
9
"Bacterial Consortium": A Potential Evolution of Fecal Microbiota Transplantation for the Treatment of Infection."细菌联合体": 用于治疗感染的粪便微生物群移植的一种潜在发展。
Biomed Res Int. 2022 Aug 8;2022:5787373. doi: 10.1155/2022/5787373. eCollection 2022.
10
The gut microbiota: a double-edged sword in endometriosis†.肠道微生物群:子宫内膜异位症的双刃剑†。
Biol Reprod. 2022 Oct 11;107(4):881-901. doi: 10.1093/biolre/ioac147.

本文引用的文献

1
Oral manifestations of Diabetes Mellitus. A systematic review.糖尿病的口腔表现。一项系统评价。
Med Oral Patol Oral Cir Bucal. 2017 Sep 1;22(5):e586-e594. doi: 10.4317/medoral.21655.
2
Colonizes Alternative Nutrient Niches during Infection across Distinct Murine Gut Microbiomes.在感染过程中,跨不同小鼠肠道微生物群定殖于替代性营养生态位。
mSystems. 2017 Jul 25;2(4). doi: 10.1128/mSystems.00063-17. eCollection 2017 Jul-Aug.
3
(Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease.(不)相信直觉:肠道微生物组与年龄相关的炎症、健康和疾病。
Microbiome. 2017 Jul 14;5(1):80. doi: 10.1186/s40168-017-0296-0.
4
Diabetes-induced mechanophysiological changes in the small intestine and colon.糖尿病引起的小肠和结肠机械生理变化。
World J Diabetes. 2017 Jun 15;8(6):249-269. doi: 10.4239/wjd.v8.i6.249.
5
Obesity and microbiota: an example of an intricate relationship.肥胖与微生物群:一种复杂关系的例证。
Genes Nutr. 2017 Jun 15;12:18. doi: 10.1186/s12263-017-0566-2. eCollection 2017.
6
[Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora].[肠道微生物群与肥胖:发病机制关系及肠道微生物群正常化的方法]
Ter Arkh. 2016;88(9):135-142. doi: 10.17116/terarkh2016889135-142.
7
Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.富含双歧杆菌的粪便供体可能是肠易激综合征患者粪便微生物群移植成功的一个积极预测指标。
Digestion. 2017;96(1):29-38. doi: 10.1159/000471919. Epub 2017 Jun 21.
8
Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?在复发性或难治性艰难梭菌感染患者中,冷冻粪便微生物群移植与新鲜粪便微生物群移植的效果是否相同:一项荟萃分析?
Diagn Microbiol Infect Dis. 2017 Aug;88(4):322-329. doi: 10.1016/j.diagmicrobio.2017.05.007. Epub 2017 May 18.
9
Fecal microbiota transplantation cured epilepsy in a case with Crohn's disease: The first report.粪便微生物群移植治愈一例克罗恩病相关癫痫:首例报告。
World J Gastroenterol. 2017 May 21;23(19):3565-3568. doi: 10.3748/wjg.v23.i19.3565.
10
Therapy of the postinfectious irritable bowel syndrome: an update.感染后肠易激综合征的治疗:最新进展
Clujul Med. 2017;90(2):133-138. doi: 10.15386/cjmed-752. Epub 2017 Apr 25.

粪便移植:消化及消化外临床应用

Fecal transplantation: digestive and extradigestive clinical applications.

作者信息

Filip Mihaela, Tzaneva Valentina, Dumitrascu Dan L

机构信息

2nd Deptartment Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Trakia University Stara Zagora, Bulgaria.

出版信息

Clujul Med. 2018 Jul;91(3):259-265. doi: 10.15386/cjmed-946. Epub 2018 Jul 31.

DOI:10.15386/cjmed-946
PMID:30093802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6082619/
Abstract

BACKGROUND AND AIM

Fecal transplantation or fecal material transplantation (FMT) became a hot topic in gastroenterology in recent years. Therefore it is important to disseminate the up-to-date information on FMT. The aim of the paper is to review the knowledge on FMT and its clinical applications.

METHODS

An extensive review of the literature was carried out. Titles from Pubmed were searched and analyzed. A narrative review has been written with emphasis on indications of FMT in different conditions.

RESULTS

The guidelines recommend FMT in relapsing infection with Clostridium difficile. Several attempts to use FMT in other conditions have been analyzed. Attempts were recorded in other bowel disorders like IBD, IBS, chronic constipation and even colorectal cancer. The attempt to change the microbiota by FMT in diabetes and obesity represent challenges for the future.

CONCLUSIONS

Fecal transplantation represents an important therapeutic method, intensively investigated these years. Beside the indication for persistent and recurrent Clostridium difficile infection, several attempts were undertaken in other intestinal diseases and in metabolic conditions. The efficiency of these applications has to be demonstrated.

摘要

背景与目的

粪便移植或粪便物质移植(FMT)近年来成为胃肠病学领域的热门话题。因此,传播有关FMT的最新信息很重要。本文旨在综述FMT的相关知识及其临床应用。

方法

对文献进行了广泛综述。检索并分析了来自PubMed的标题。撰写了一篇叙述性综述,重点关注FMT在不同情况下的适应证。

结果

指南推荐FMT用于艰难梭菌复发性感染。分析了在其他情况下使用FMT的几次尝试。记录了在其他肠道疾病如炎症性肠病(IBD)、肠易激综合征(IBS)、慢性便秘甚至结直肠癌中的尝试。通过FMT改变糖尿病和肥胖患者的微生物群的尝试是未来的挑战。

结论

粪便移植是近年来深入研究的一种重要治疗方法。除了用于持续性和复发性艰难梭菌感染的适应证外,还在其他肠道疾病和代谢性疾病中进行了几次尝试。这些应用的有效性还有待证实。